Stay updated with breaking news from Upper Limb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A recent clinical trial led by the University of California has shown that cellular therapy is safe and effective in stopping the deterioration of upper limb and heart functions in patients with late-stage Duchenne muscular dystrophy.
A clinical trial at UC Davis Health and six other sites showed that a cellular therapy offers promise for patients with late-stage Duchenne muscular dystrophy (DMD), a rare genetic disorder causing muscle loss and physical impairments in young people.
Duchenne muscular dystrophy (DMD), the most common form of muscular dystrophy, is an X-linked recessive disease that affects approximately one in...
Upper Limb Prosthetics Market to Worth $1.04 Billion by 2030 | By Product, Business & Application
Upper Limb Prosthetics Market to Worth $1.04 Billion by 2030 | By Product, Business & Application